10469 related articles for article (PubMed ID: 24113773)
1. Inferring tumour purity and stromal and immune cell admixture from expression data.
Yoshihara K; Shahmoradgoli M; Martínez E; Vegesna R; Kim H; Torres-Garcia W; Treviño V; Shen H; Laird PW; Levine DA; Carter SL; Getz G; Stemke-Hale K; Mills GB; Verhaak RG
Nat Commun; 2013; 4():2612. PubMed ID: 24113773
[TBL] [Abstract][Full Text] [Related]
2. Inferring copy number and genotype in tumour exome data.
Amarasinghe KC; Li J; Hunter SM; Ryland GL; Cowin PA; Campbell IG; Halgamuge SK
BMC Genomics; 2014 Aug; 15(1):732. PubMed ID: 25167919
[TBL] [Abstract][Full Text] [Related]
3. A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study.
Sun R; Limkin EJ; Vakalopoulou M; Dercle L; Champiat S; Han SR; Verlingue L; Brandao D; Lancia A; Ammari S; Hollebecque A; Scoazec JY; Marabelle A; Massard C; Soria JC; Robert C; Paragios N; Deutsch E; Ferté C
Lancet Oncol; 2018 Sep; 19(9):1180-1191. PubMed ID: 30120041
[TBL] [Abstract][Full Text] [Related]
4. The murine Microenvironment Cell Population counter method to estimate abundance of tissue-infiltrating immune and stromal cell populations in murine samples using gene expression.
Petitprez F; Levy S; Sun CM; Meylan M; Linhard C; Becht E; Elarouci N; Tavel D; Roumenina LT; Ayadi M; Sautès-Fridman C; Fridman WH; de Reyniès A
Genome Med; 2020 Oct; 12(1):86. PubMed ID: 33023656
[TBL] [Abstract][Full Text] [Related]
5. A reference profile-free deconvolution method to infer cancer cell-intrinsic subtypes and tumor-type-specific stromal profiles.
Wang L; Sebra RP; Sfakianos JP; Allette K; Wang W; Yoo S; Bhardwaj N; Schadt EE; Yao X; Galsky MD; Zhu J
Genome Med; 2020 Feb; 12(1):24. PubMed ID: 32111252
[TBL] [Abstract][Full Text] [Related]
6. Estimation of immune cell content in tumour tissue using single-cell RNA-seq data.
Schelker M; Feau S; Du J; Ranu N; Klipp E; MacBeath G; Schoeberl B; Raue A
Nat Commun; 2017 Dec; 8(1):2032. PubMed ID: 29230012
[TBL] [Abstract][Full Text] [Related]
7. AbsCN-seq: a statistical method to estimate tumor purity, ploidy and absolute copy numbers from next-generation sequencing data.
Bao L; Pu M; Messer K
Bioinformatics; 2014 Apr; 30(8):1056-1063. PubMed ID: 24389661
[TBL] [Abstract][Full Text] [Related]
8. OncoSNP-SEQ: a statistical approach for the identification of somatic copy number alterations from next-generation sequencing of cancer genomes.
Yau C
Bioinformatics; 2013 Oct; 29(19):2482-4. PubMed ID: 23926227
[TBL] [Abstract][Full Text] [Related]
9. RF_Purify: a novel tool for comprehensive analysis of tumor-purity in methylation array data based on random forest regression.
Johann PD; Jäger N; Pfister SM; Sill M
BMC Bioinformatics; 2019 Aug; 20(1):428. PubMed ID: 31419933
[TBL] [Abstract][Full Text] [Related]
10. Assessing breast cancer cell lines as tumour models by comparison of mRNA expression profiles.
Vincent KM; Findlay SD; Postovit LM
Breast Cancer Res; 2015 Aug; 17(1):114. PubMed ID: 26289960
[TBL] [Abstract][Full Text] [Related]
11. MixClone: a mixture model for inferring tumor subclonal populations.
Li Y; Xie X
BMC Genomics; 2015; 16 Suppl 2(Suppl 2):S1. PubMed ID: 25707430
[TBL] [Abstract][Full Text] [Related]
12. Gene expression profiles of pancreatic cancer and stromal desmoplasia.
Crnogorac-Jurcevic T; Efthimiou E; Capelli P; Blaveri E; Baron A; Terris B; Jones M; Tyson K; Bassi C; Scarpa A; Lemoine NR
Oncogene; 2001 Nov; 20(50):7437-46. PubMed ID: 11704875
[TBL] [Abstract][Full Text] [Related]
13. ESTIMATE algorithm is not appropriate for inferring tumor purity and stromal and immune cell admixture in hematopoietic or stromal tumors.
Liu Q; Fang Y; Wang J
Cancer Immunol Immunother; 2020 Jun; 69(6):1153-1154. PubMed ID: 32152701
[No Abstract] [Full Text] [Related]
14. Development of a predictive model for stromal content in prostate cancer samples to improve signature performance.
Boufaied N; Takhar M; Nash C; Erho N; Bismar TA; Davicioni E; Thomson AA
J Pathol; 2019 Dec; 249(4):411-424. PubMed ID: 31206668
[TBL] [Abstract][Full Text] [Related]
15. Impact of Tumor Purity on Immune Gene Expression and Clustering Analyses across Multiple Cancer Types.
Rhee JK; Jung YC; Kim KR; Yoo J; Kim J; Lee YJ; Ko YH; Lee HH; Cho BC; Kim TM
Cancer Immunol Res; 2018 Jan; 6(1):87-97. PubMed ID: 29141981
[TBL] [Abstract][Full Text] [Related]
16. Single-cell transcriptome analysis of endometrial tissue.
Krjutškov K; Katayama S; Saare M; Vera-Rodriguez M; Lubenets D; Samuel K; Laisk-Podar T; Teder H; Einarsdottir E; Salumets A; Kere J
Hum Reprod; 2016 Apr; 31(4):844-53. PubMed ID: 26874359
[TBL] [Abstract][Full Text] [Related]
17. Next-generation sequence analysis of cancer xenograft models.
Rossello FJ; Tothill RW; Britt K; Marini KD; Falzon J; Thomas DM; Peacock CD; Marchionni L; Li J; Bennett S; Tantoso E; Brown T; Chan P; Martelotto LG; Watkins DN
PLoS One; 2013; 8(9):e74432. PubMed ID: 24086345
[TBL] [Abstract][Full Text] [Related]
18. Interactive analysis of large cancer copy number studies with Copy Number Explorer.
Newman S
Bioinformatics; 2015 Sep; 31(17):2874-6. PubMed ID: 25957352
[TBL] [Abstract][Full Text] [Related]
19. Inferring structural variant cancer cell fraction.
Cmero M; Yuan K; Ong CS; Schröder J; ; Corcoran NM; Papenfuss T; Hovens CM; Markowetz F; Macintyre G;
Nat Commun; 2020 Feb; 11(1):730. PubMed ID: 32024845
[TBL] [Abstract][Full Text] [Related]
20. Genomic data analysis workflows for tumors from patient-derived xenografts (PDXs): challenges and guidelines.
Woo XY; Srivastava A; Graber JH; Yadav V; Sarsani VK; Simons A; Beane G; Grubb S; Ananda G; Liu R; Stafford G; Chuang JH; Airhart SD; Karuturi RKM; George J; Bult CJ
BMC Med Genomics; 2019 Jul; 12(1):92. PubMed ID: 31262303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
